ArticleGeburtshilfe und Frauenheilkunde2023

Comparison of Biosimilar Trastuzumab ABP 980 with Reference Trastuzumab in Neoadjuvant Therapy for HER2-positive Breast Cancer - an Analysis of a Large University Breast Cancer Centre.

Sabine Matovina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.